US Stock MarketDetailed Quotes
AKTX Akari Therapeutics
- 2.2400
- -0.0600-2.61%
Close Nov 13 16:00 ET
27.20MMarket Cap-761P/E (TTM)
2.3914High2.2300Low5.52KVolume2.2300Open2.3000Pre Close12.56KTurnover0.10%Turnover RatioLossP/E (Static)12.14MShares4.400052wk High-7.34P/B12.23MFloat Cap1.077552wk Low--Dividend TTM5.46MShs Float5000.0000Historical High--Div YieldTTM7.02%Amplitude1.0775Historical Low2.2750Avg Price1Lot Size
Akari Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q2)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -41.83%4.18M | --1.31M | -70.98%3.85M | -11.91%7.18M | 41.54%13.25M | 114.98%8.15M | 150.78%16.72M | -33.40%9.36M | -33.40%9.36M | 8.71%13.39M |
| -Cash and cash equivalents | -41.83%4.18M | --1.31M | -70.98%3.85M | -11.91%7.18M | 41.54%13.25M | 114.98%8.15M | 150.78%16.72M | -33.40%9.36M | -33.40%9.36M | 8.71%13.39M |
| Prepaid assets | 27.79%805K | --1.23M | -35.70%299K | -79.59%629.94K | -78.61%465K | 204.79%3.09M | 108.32%2.39M | 642.63%2.17M | 642.63%2.17M | -3.38%1.3M |
| Other current assets | -49.62%94K | --232K | 97.00%197K | 61.99%186.57K | 10.74%100K | --115.17K | --325.74K | -60.60%90.3K | -60.60%90.3K | ---- |
| Total current assets | -36.53%5.08M | --2.77M | -68.58%4.34M | -29.55%8M | 18.84%13.82M | 136.31%11.35M | 148.72%19.43M | -20.25%11.63M | -20.25%11.63M | 7.52%14.69M |
| Non current assets | ||||||||||
| Goodwill and other intangible assets | --0 | --0 | -17.65%14K | -16.27%15.78K | -25.86%17K | -26.24%18.84K | -19.37%21.34K | -15.55%22.93K | -15.55%22.93K | -10.30%23.93K |
| -Other intangible assets | ---- | ---- | -17.65%14K | -16.27%15.78K | -25.86%17K | -26.24%18.84K | -19.37%21.34K | -15.55%22.93K | -15.55%22.93K | -10.30%23.93K |
| Total non current assets | --0 | --0 | -17.65%14K | -16.27%15.78K | -25.86%17K | -26.24%18.84K | -19.37%21.34K | -15.55%22.93K | -15.55%22.93K | -10.30%23.93K |
| Total assets | -36.65%5.08M | --2.77M | -68.52%4.36M | -29.53%8.01M | 18.75%13.83M | 135.45%11.37M | 148.15%19.45M | -20.25%11.65M | -20.25%11.65M | 7.48%14.72M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 354.68%4.69M | --3.21M | 76.45%1.67M | -36.96%1.03M | -47.05%947K | -2.99%1.63M | 8.63%3.08M | -47.10%1.79M | -47.10%1.79M | -20.21%1.92M |
| -accounts payable | 354.68%4.69M | --3.21M | 76.45%1.67M | -36.96%1.03M | -47.05%947K | -2.99%1.63M | 8.63%3.08M | -47.10%1.79M | -47.10%1.79M | -20.21%1.92M |
| Current accrued expenses | -45.55%1.31M | --1.11M | -19.92%1.38M | 70.29%2.4M | -45.93%1.72M | -9.38%1.41M | 128.49%2.45M | 73.12%3.18M | 73.12%3.18M | 46.78%1.43M |
| Current debt and capital lease obligation | --1M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Current debt | --1M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other current liabilities | -21.73%1.41M | --1.59M | -83.05%1.35M | --1.8M | 609.46%7.95M | ---- | ---- | --1.12M | --1.12M | ---- |
| Current liabilities | 67.81%8.78M | --6.33M | -61.93%4.58M | 71.79%5.23M | 97.61%12.04M | -6.06%3.05M | 41.52%5.52M | 16.72%6.09M | 16.72%6.09M | -62.02%3.36M |
| Non current liabilities | ||||||||||
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total liabilities | 67.81%8.78M | --6.33M | -61.93%4.58M | 71.79%5.23M | 97.61%12.04M | -6.06%3.05M | 41.52%5.52M | 16.72%6.09M | 16.72%6.09M | -62.02%3.36M |
| Shareholders'equity | ||||||||||
| Share capital | 140.06%2.43M | --1.6M | 77.72%1.32M | 70.56%1.01M | 56.52%745K | 49.68%593.49K | 54.26%593.49K | 23.72%475.97K | 23.72%475.97K | -98.98%475.97K |
| -common stock | 140.06%2.43M | --1.6M | 77.72%1.32M | 70.56%1.01M | 56.52%745K | 49.68%593.49K | 54.26%593.49K | 23.72%475.97K | 23.72%475.97K | -98.98%475.97K |
| Retained earnings | -9.13%-240.59M | ---233.03M | -4.60%-227.46M | -4.70%-220.45M | -8.89%-217.45M | -9.40%-210.56M | -8.91%-204.88M | -9.56%-199.71M | -9.56%-199.71M | -25.78%-193.92M |
| Paid-in capital | 5.45%235.2M | --228.64M | 3.50%226.95M | 1.89%223.05M | 6.79%219.27M | 12.80%218.92M | 13.95%218.79M | 6.98%205.32M | 6.98%205.32M | 81.53%205.25M |
| Gains losses not affecting retained earnings | 9.31%-749K | ---761K | -34.89%-1.04M | -32.87%-825.88K | -42.52%-771K | -47.96%-621.56K | -67.65%-573.32K | 16.53%-540.97K | 16.53%-540.97K | 27.99%-447.42K |
| Total stockholders'equity | -233.13%-3.7M | ---3.55M | -112.79%-229K | -66.59%2.78M | -67.76%1.79M | 424.30%8.33M | 253.87%13.93M | -40.81%5.55M | -40.81%5.55M | 133.88%11.36M |
| Total equity | -233.13%-3.7M | ---3.55M | -112.79%-229K | -66.59%2.78M | -67.76%1.79M | 424.30%8.33M | 253.87%13.93M | -40.81%5.55M | -40.81%5.55M | 133.88%11.36M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | Unqualified Opinion with Explanatory Notes | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data